You are here

Article Text

Article menu
Download PDFPDF
Electronic pages
Case report
Solitaire FR device for treatment of dural sinus thrombosis
  1. Bryan Anthony Pukenas1,
  2. Monisha Kumar2,
  3. Michael Stiefel3,
  4. Michelle Smith4,
  5. Robert Hurst1
  1. 1Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  2. 2Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  3. 3Department of Neurosurgery, Westchester Medical Center, New York, New York, USA
  4. 4Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  1. Correspondence to Dr Bryan Anthony Pukenas, bryan.pukenas{at}uphs.upenn.edu

Abstract

Dural venous sinus thrombosis is a rare and potentially devastating disease. Several predisposing factors exist, including oral contraceptive therapy and colitis. First-line therapy consists of systemic anticoagulation. If first-line therapies fail, more aggressive endovascular therapies may be performed. We report our initial experience with the Solitaire FR device for treatment of refractory symptomatic dural venous sinus thrombosis.

  • Brain
  • Intervention
  • Stent
  • Thrombectomy
  • Vein

https://doi.org/10.1136/neurintsurg-2012-010543.rep

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text